Triomics Raises $22 Million to Bring Oncology-Specific AI to Cancer Centers
Triomics raised a $22 million Series B to expand AI tools for oncology clinical workflows and trial matching.
Triomics raised a $22 million Series B to expand AI tools for oncology clinical workflows and trial matching.
Latest News and Analysis in Triomics